InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: Double_Bagel post# 13397

Sunday, 04/19/2015 4:23:01 PM

Sunday, April 19, 2015 4:23:01 PM

Post# of 20689

What was the reason for CHRS to shoot up from $15 to $33 earlier this year?

The attention directed to the FoB arena by FDA approval of Xarxio—the first approval via the 351(k) regulatory pathway.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”